1 / 1

Optimization of Partial Hydrogenation Parameters

PARTIAL ALKYNE REDUCTION IN FLOW: ADAPTATION OF THE LINDLAR PROTOCOL PROMPTED BY A FLOW SYNTHESIS OF COMBRETASTATIN A-4 Laurent De Backer, Eduard Dolušić , Stéphane Collin and Steve Lanners * Laboratoire de Chimie Organique de Synthèse , Namur Medicine & Drug Innovation Center (NAMEDIC ),

janina
Download Presentation

Optimization of Partial Hydrogenation Parameters

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. PARTIAL ALKYNE REDUCTION IN FLOW: ADAPTATION OF THE LINDLAR PROTOCOL PROMPTED BY A FLOW SYNTHESIS OF COMBRETASTATIN A-4 Laurent De Backer, Eduard Dolušić, Stéphane Collin and Steve Lanners* Laboratoire de Chimie Organique de Synthèse, Namur Medicine & Drug Innovation Center (NAMEDIC), Namur Research Institute for Life Sciences (NARILIS), Université de Namur, rue de Bruxelles 61, B-5000 Namur, Belgium eduard.dolusic@unamur.be Introduction Combretastatin A-4 (1) is a natural product isolated from the South African bushwillow tree Combretumcaffrumand endowed with a powerful inhibitory activity on microtubule formation as well as a related antiangiogenic activity.1As such, 1 has a strong potential in anticancer therapy. A lot of effort has been done on the development of new derivatives of this compound, in order to improve the properties such as solubility and stability, and to understand the structure-activity relationships around this series.2 Envisaged Flow Synthesis of 1 Optimization of Partial Hydrogenation Parameters The synthesis of active pharmaceutical ingredients (API) using only flow chemistry has been pioneered by S.V. Ley et. al. in 2010.3 In order to further illustrate the feasibility of this strategy, we have devised a synthetic route for 1 which only relies on flow chemistry (Scheme 1). The envisaged Bestmann-Ohira4aand Sonogashira4breactions have already been accomplished in flow. However, we anticipated that the partial hydrogenation of alkyne 5might be problematic. Lindlar-type hydrogenation of disubstitutedalkynes using H-Cube® (Fig. 1.) has been described,4cbut not on bis-aryl alkynes. We used diphenylacetylene6 as the model substrate. Various reaction parameters were investigated. The selected results are shown in Table 1. The selected conditions were used with moderate success in a preliminary assay of hydrogenation of the alkyne precursor of 1 (Scheme 2). Figure 1. ThalesNano H-Cube® Table 1. Hydrogenation of diphenylacetylene6. Product ratios were determined by integration of relevant signals in the 1H-NMR spectra of the crude reaction mixtures (extraction with 5% aq. HCl when quinoline added) Scheme 2. Synthesis of combretastatin A-4 using Lindlar hydrogenation in flow Scheme 1. Proposed flow synthesis of Combretastatin A-4 Extending the Reaction Scope and Conclusion We decided to expand the optimized reaction conditions to a wider range of structurally various alkynes (Scheme 3 and Table 2). In some cases (substrates 16 and 17), mixtures with alcohols were used as the solvents to ensure complete solubility. The above optimized conditions gave good results for the less reactive alkynes (10 – 12); in the latter case, 10 bar of H2 had to be applied to achieve a satisfactory outcome. On the other hand, adding as much as 5 equiv. of quinoline could not completely suppress overreduction of the more reactive substrates. In conclusion, while the generality of our method is reasonable within the substrate scope explored, fine tuning of the reaction conditions is still necessary in order to improve the selectivity towards (Z)-alkenes. Scheme 3. Lindlar hydrogenation in flow of a range of alkynes 10 16 14 12 13 17 11 15 Table 2. Lindlar hydrogenations in flow. Product ratios were determined by integration of relevant signals in the 1H-NMR spectra of the crude reaction mixtures (extraction with 5% aq. HCl) References and Acknowledgment • 1. a) Lin, C. M., et al, Mol. Pharmacol. 1988, 34, 200; b) Holt, H., et al, Top. Heterocycl. Chem. 2006, 11, 465; c) Kerr, D. J., et al, Bioorg. Med. Chem. 2007, 15, 3290. • 2. a) Marrelli, M., et al, Curr. Med. Chem. 2011, 18, 3035; b) Shan, Y., et al, Curr. Med. Chem. 2011, 18, 523; c) Spatafora, C., et al, Anticancer Agents Med. Chem. 2012, 12, 902; d) Mikstacka, R., et al, Cell.Mol. Biol. Lett. 2013, 18, 368. • 3. Hopkin, M. D., et al, Chem. Comm. 2010, 2450. • 4. a) Baxendale, I. R., et al, Angew. Chem. Int. Ed. 2009, 48, 4017; b) Zhang, Y., et al, Org. Lett. 2011, 13, 280; c) Chandrasekhar, S., et al, TetrahedronLett. 2011, 52, 3865. • This work is supported by WBGREEN – MICROECO (Convention No. 1217714).

More Related